UN 
- MSF’s $50 million malaria outreach launched in northern Nigeria in February 2024.
- Programme targets 1 million children under 5 by end-Q1 2024.
- Nigeria accounts for 31% of global malaria deaths, per WHO 2023.
Nigeria remains the global epicentre of malaria mortality, with the World Health Organization (WHO) reporting in 2023 that the country accounted for 31% of all malaria fatalities worldwide. Médecins Sans Frontières, known for its emergency medical work, is focusing its newest campaign on high-burden states in northern Nigeria, such as Kano and Zamfara. The campaign’s chief objective is to distribute preventive treatment and ensure rapid testing and treatment for children under the age of five, a demographic bearing the highest mortality risk.
The $50 million funding will support a combination of seasonal malaria chemoprevention (SMC), mosquito net distribution, and community education, according to Dr. Aisha Ahmad, Nigeria country coordinator for MSF. SMC delivery is scheduled during the upcoming rainy season, the period of highest malaria transmission. MSF is working in partnership with Nigeria’s National Malaria Elimination Programme and aims to publish a full transparency report on the campaign’s reach and impact by early 2026.
While Nigeria’s National Malaria Strategic Plan (2021â2025) has set a target to reduce malaria prevalence to less than 10% by the end of 2025, current progress remains uneven. According to official data from Nigeria’s Ministry of Health, coverage gaps persist in rural and conflict-affected regions, where MSF’s outreach will be concentrated. Experts note that the new MSF funding represents a significant increaseânearly 20%âin dedicated international resources for malaria prevention in Nigeria for 2024.
Sustainability professionals caution that while MSF’s intervention is substantial, regular independent evaluation is required to avoid greenwashing and ensure that outreach translates into reduced incidence and mortality. As the 2026 milestone approaches, stakeholders will look to verifiable health outcomes rather than headline figures to measure lasting impact.
Frequently Asked Questions
What makes MSF’s malaria campaign different from previous interventions in Nigeria?
This is the largest single-year malaria outreach investment by MSF in West Africa to date, targeting 1 million children in high-risk zones with a combined approach of preventive medication, mosquito nets, and localized education. The focus on real-time monitoring and an explicit 2026 delivery anchor distinguishes it from prior, less-targeted interventions.
How will progress be measured and publicly reported?
MSF, in coordination with Nigeria’s National Malaria Elimination Programme, will use biometric data, treatment logs, and independent third-party audits to track the number of children reached, reductions in malaria incidence, and community feedback. A full impact report is scheduled for publication in Q1 2026.
Is there evidence of greenwashing or unmet pledges in this campaign?
As of launch, MSF has earmarked all $50 million for direct service delivery and has published initial disbursement and implementation plans. Stakeholders remain vigilant for delivery gaps, but current oversight mechanisms appear robust and transparent by international NGO standards.
Frequently Asked Questions
What is Médecins Sans Frontières’ new malaria initiative in Nigeria?
Médecins Sans Frontières (MSF) is investing $50 million in a malaria outreach campaign aiming to reach 1 million children under five in northern Nigeria by the end of Q1 2024.
Why is Nigeria the focus of MSF’s malaria campaign?
Nigeria accounts for 31% of global malaria deaths according to WHO 2023 data, making it the global epicentre of malaria mortality.
What methods will MSF use to combat malaria in Nigeria?
MSF will combine seasonal malaria chemoprevention (SMC), mosquito net distribution, and community education, focusing on high-burden states like Kano and Zamfara.
How will MSF measure and report the impact of its malaria outreach?
Progress will be tracked using biometric data, treatment logs, and independent third-party audits, with a full impact report scheduled for publication in Q1 2026.
How does this MSF campaign differ from previous malaria interventions in Nigeria?
This is MSF’s largest single-year malaria outreach in West Africa, targeting 1 million children with a combined approach and real-time monitoring anchored to a 2026 delivery milestone.
